Recent 8-K filings for AIBT

• August 21, 2024, 7:59 PM ET other material materiality 0.85 neutral item 1.01item 5.03item 9.01

  Mycotopia exchanges 9.79M common shares for super voting preferred; Ehave gets 75% voting control

  Ehave Inc. exchanged 9,793,754 common shares (≈67% of outstanding) for 1,000 Series A Super Voting Preferred shares.

• December 5, 2023, 6:59 PM ET M&A materiality 0.70 positive item 1.01item 2.01item 3.02item 7.01item 9.01 ◈ M&A Transactions

  Mycotopia Therapies acquires AI robotics assets from Philon Labs; up to $9M in stock, to rename AiBotics

  Acquires patents for Phill Robot (AI massage robot) and Milky Way (smart breast-milk fridge) from Philon Labs.

• May 3, 2023, 7:59 PM ET other material materiality 0.85 negative item 4.02 ◈ Auditor Changes

  Mycotopia to restate 2022 financial statements; $288K cash comp and warrant to CEO omitted

  Unrecorded $288,000 cash compensation and a warrant for 5% of fully diluted shares granted to CEO.

• February 22, 2023, 6:59 PM ET other material materiality 0.60 negative item 1.02item 7.01item 9.01 ◈ Material Agreements

  Mycotopia Therapies, PSLY.com, and Ei.Ventures mutually terminate merger agreement

  Parties agreed to terminate the Agreement and Plan of Merger dated May 17, 2022 on February 16, 2023.

• May 19, 2022, 7:59 PM ET M&A materiality 0.75 positive item 1.01item 7.01item 9.01

  Mycotopia enters merger with Ei.Ventures under PSLY.com; total deal value ~$383M

  Mycotopia shareholders to receive 0.25 PSLY.com share per TPIA share, valued at >$23M.

• January 14, 2022, 6:59 PM ET leadership materiality 0.60 neutral item 1.01item 9.01

  Mycotopia Therapies appoints Benjamin Kaplan as CEO; $24k/mo consulting fee, 5% equity warrants

  CEO appointment effective Jan 19, 2021; initial 36-month term with automatic 12-month renewal.

Materiality & sentiment trend

Max materiality 0.85 · Median 0.65 · Most common event other_material

2 positive 2 negative 4 neutral

source · AIBT on sec.gov